New developments in the pharmacotherapy of inflammatory bowel disease

This publication has 61 references indexed in Scilit:

• Olsalazine
  Drugs, 1991
• Risk-Benefit Assessment of Drugs Used in the Treatment of Inflammatory Bowel Disease
  Drug Safety, 1991
• Dissolution profiles of mesalazine formulationsin vitro
  International Journal of Clinical Pharmacy, 1990
• Is Trimethoprim-Sulfamethoxazole Helpful in Crohnʼs Disease?
  Journal of Clinical Gastroenterology, 1990
• Clinical Pharmacokinetics of Drugs Used in the Treatment of Gastrointestinal Diseases (Part II)
  Clinical Pharmacokinetics, 1990
• Aetiology and pathogenesis of ulcerative colitis and Crohn’s disease
  Postgraduate Medical Journal, 1989
• A Placebo-Controlled, Double-Blind, Randomized Trial of Cyclosporine Therapy in Active Chronic Crohn's Disease
  New England Journal of Medicine, 1989
• Immunosuppressive Drugs in Inflammatory Bowel Disease
  Drugs, 1989
• Oxygen radicals: mediators of gastrointestinal pathophysiology.
  Gut, 1989
• Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis.
  Gut, 1987